Endogenous endophthalmitis following prolong use of methotrexate

Vishal Katiyar, Ankur Yadav, Prateep Phadikar, S. Gupta
{"title":"Endogenous endophthalmitis following prolong use of methotrexate","authors":"Vishal Katiyar, Ankur Yadav, Prateep Phadikar, S. Gupta","doi":"10.4103/2347-5617.179350","DOIUrl":null,"url":null,"abstract":"A 46 yr old male presented to us with a 2 day history of pain, redness and discharge in left eye. The patient was on oral Methotrexate (12.5 mg) weekly with folic acid supplement for the last 1 year for recurrent Uveitis (LE). There was a history of three previous episodes of acute anterior uveitis in left eye 2 years back for which he was prescribed oral steroids. The uveitis attack use to flare up on tapering the steroids. In the hope to reduce the recurrences and to prevent long-term complications, the patient was shifted to oral methotrexate (12.5 mg) weekly with folic acid supplementation. On the basis of clinical examination and B- scan a presumptive diagnosis of endogenous endophthalmitis was made. Vitreous tap revealed a straw colored sample and the culture subsequently grew methicillin sensitive Staphylococcus epidermidis. Intravitreal injection of (Piperacillin+Tazobactum) 225 microgram in 0.1 ml was administered. In addition, intravenous (piperacillin+tazobactum) 4.5 gram BD was given for 3 days. Post intra vitreal injection the symtoms and signs resolved remarkably. Methotrexate has not been previously implicated with endogenous endophthalmitis. Besides, Endogenous endophthalmitis is an ongoing diagnostic and therapeutic dilemma for ophthalmologists as it is relatively rare and often presents like uveitis. It requires a high index of suspicion for prompt diagnosis and treatment. The treatment of EE is still controversial due to a lack of clinical trials. Future large group studies need to be done for validation of the above therapeutic regime.","PeriodicalId":201997,"journal":{"name":"Egyptian Retina Journal","volume":"14 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Retina Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2347-5617.179350","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 46 yr old male presented to us with a 2 day history of pain, redness and discharge in left eye. The patient was on oral Methotrexate (12.5 mg) weekly with folic acid supplement for the last 1 year for recurrent Uveitis (LE). There was a history of three previous episodes of acute anterior uveitis in left eye 2 years back for which he was prescribed oral steroids. The uveitis attack use to flare up on tapering the steroids. In the hope to reduce the recurrences and to prevent long-term complications, the patient was shifted to oral methotrexate (12.5 mg) weekly with folic acid supplementation. On the basis of clinical examination and B- scan a presumptive diagnosis of endogenous endophthalmitis was made. Vitreous tap revealed a straw colored sample and the culture subsequently grew methicillin sensitive Staphylococcus epidermidis. Intravitreal injection of (Piperacillin+Tazobactum) 225 microgram in 0.1 ml was administered. In addition, intravenous (piperacillin+tazobactum) 4.5 gram BD was given for 3 days. Post intra vitreal injection the symtoms and signs resolved remarkably. Methotrexate has not been previously implicated with endogenous endophthalmitis. Besides, Endogenous endophthalmitis is an ongoing diagnostic and therapeutic dilemma for ophthalmologists as it is relatively rare and often presents like uveitis. It requires a high index of suspicion for prompt diagnosis and treatment. The treatment of EE is still controversial due to a lack of clinical trials. Future large group studies need to be done for validation of the above therapeutic regime.
长期使用甲氨蝶呤引起内源性眼内炎
46岁男性,左眼疼痛、红肿、流脓2天。由于复发性葡萄膜炎(LE),患者每周口服甲氨蝶呤(12.5 mg)并补充叶酸1年。2年前有三次左眼急性前葡萄膜炎病史,曾服用口服类固醇。在逐渐减少类固醇治疗时,葡萄膜炎会突然发作。为了减少复发和预防长期并发症,患者改为每周口服甲氨蝶呤(12.5 mg)并补充叶酸。在临床检查和B超检查的基础上,推定为内源性眼内炎。玻璃水龙头显示稻草色样品,随后培养出甲氧西林敏感的表皮葡萄球菌。玻璃体内注射(哌拉西林+他唑巴坦)225微克,0.1 ml。同时静脉滴注(哌拉西林+他唑巴坦)BD 4.5 g,连续3天。玻璃体内注射后症状和体征明显缓解。甲氨蝶呤以前并未与内源性眼内炎有关。此外,内源性眼内炎是困扰眼科医生的诊断和治疗难题,因为它相对罕见,常表现为葡萄膜炎。它需要高度的怀疑指数,以便及时诊断和治疗。由于缺乏临床试验,情感表达的治疗仍然存在争议。为了验证上述治疗方案,未来需要进行大规模的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信